DE602004024312D1 - Verwendung von cxcl6 chemokin bei der prävention oder reparatur von knorpeldefekten - Google Patents

Verwendung von cxcl6 chemokin bei der prävention oder reparatur von knorpeldefekten

Info

Publication number
DE602004024312D1
DE602004024312D1 DE602004024312T DE602004024312T DE602004024312D1 DE 602004024312 D1 DE602004024312 D1 DE 602004024312D1 DE 602004024312 T DE602004024312 T DE 602004024312T DE 602004024312 T DE602004024312 T DE 602004024312T DE 602004024312 D1 DE602004024312 D1 DE 602004024312D1
Authority
DE
Germany
Prior art keywords
cxcl6
repair
chemokin
prevention
cartilage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004024312T
Other languages
English (en)
Inventor
Frank Luyten
Bari Cosimo De
Accio Francesco Dell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tigenix NV
Original Assignee
Tigenix NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34135345&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602004024312(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tigenix NV filed Critical Tigenix NV
Publication of DE602004024312D1 publication Critical patent/DE602004024312D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/195—Chemokines, e.g. RANTES
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE602004024312T 2003-08-12 2004-08-12 Verwendung von cxcl6 chemokin bei der prävention oder reparatur von knorpeldefekten Active DE602004024312D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49451603P 2003-08-12 2003-08-12
PCT/BE2004/000117 WO2005014026A2 (en) 2003-08-12 2004-08-12 Use of cxcl6 chemokine in the prevention or repair of cartilage defects

Publications (1)

Publication Number Publication Date
DE602004024312D1 true DE602004024312D1 (de) 2010-01-07

Family

ID=34135345

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004024312T Active DE602004024312D1 (de) 2003-08-12 2004-08-12 Verwendung von cxcl6 chemokin bei der prävention oder reparatur von knorpeldefekten

Country Status (16)

Country Link
US (2) US7485310B2 (de)
EP (1) EP1653994B1 (de)
JP (1) JP4920412B2 (de)
AT (1) ATE449608T1 (de)
AU (1) AU2004262451B2 (de)
CA (1) CA2533124C (de)
DE (1) DE602004024312D1 (de)
DK (1) DK1653994T3 (de)
ES (1) ES2337469T3 (de)
HK (1) HK1085656A1 (de)
IL (1) IL173544A (de)
NO (1) NO338152B1 (de)
NZ (1) NZ545702A (de)
PL (1) PL1653994T3 (de)
RU (1) RU2363491C2 (de)
WO (1) WO2005014026A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050222687A1 (en) * 2004-04-02 2005-10-06 Gordana Vunjak-Novakovic Cartilage implant assembly and method for implantation
US7067123B2 (en) * 2003-04-29 2006-06-27 Musculoskeletal Transplant Foundation Glue for cartilage repair
US7901457B2 (en) * 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
US20090291112A1 (en) * 2003-05-16 2009-11-26 Truncale Katherine G Allograft osteochondral plug combined with cartilage particle mixture
US7837740B2 (en) 2007-01-24 2010-11-23 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
US20080220044A1 (en) * 2007-03-06 2008-09-11 Semler Eric J Cancellous construct with support ring for repair of osteochondral defects
US7815926B2 (en) 2005-07-11 2010-10-19 Musculoskeletal Transplant Foundation Implant for articular cartilage repair
US8921109B2 (en) 2005-09-19 2014-12-30 Histogenics Corporation Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
US8435551B2 (en) 2007-03-06 2013-05-07 Musculoskeletal Transplant Foundation Cancellous construct with support ring for repair of osteochondral defects
EP2224884A2 (de) * 2007-12-05 2010-09-08 Musculoskeletal Transplant Foundation Spongiosa-implantat zur knorpelreparatur
WO2009111069A1 (en) * 2008-03-05 2009-09-11 Musculoskeletal Transplant Foundation Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
EP2331581A1 (de) 2008-09-22 2011-06-15 Arcarios B.V. Carboxyethylierte cyclodextrinpolysulfate, die zur verwendung als medikamente geeignet sind
GB0820492D0 (en) 2008-11-07 2008-12-17 Sportcell Cell compositions and uses thereof
ES2597954T3 (es) * 2009-07-27 2017-01-24 Baxalta GmbH Conjugados de proteína de la coagulación sanguínea
JP5657009B2 (ja) * 2009-10-23 2015-01-21 ケー−ステムセル カンパニー リミテッドＫ−Ｓｔｅｍｃｅｌｌ Ｃｏ．， Ｌｔｄ． 脂肪組織由来成体幹細胞遊走を誘導する方法
US8687070B2 (en) * 2009-12-22 2014-04-01 Apple Inc. Image capture device having tilt and/or perspective correction
KR101793806B1 (ko) 2013-03-15 2017-11-03 더블유.엘. 고어 앤드 어소시에이트스, 인코포레이티드 저 표면 에너지 구조를 위한 수성 전달 시스템
US20160017046A1 (en) * 2013-03-29 2016-01-21 Merrimack Pharmaceuticals, Inc. Compositions and methods for treating osteolytic bone disorders
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
CN116904520B (zh) * 2023-09-13 2024-01-09 中国人民解放军军事科学院军事医学研究院 制备重组软骨祖细胞的方法及获得的重组软骨祖细胞与应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6413511B1 (en) * 1990-12-20 2002-07-02 University Of Pittsburgh Of The Commonwealth System Of Higher Education Cartilage alterations by administering to joints chondrocytes comprising a heterologous polynucleotide
EP0804486B1 (de) * 1992-11-27 2008-10-01 Laboratoires Serono SA Chemotaktisches protein für granulozyten
US5723331A (en) * 1994-05-05 1998-03-03 Genzyme Corporation Methods and compositions for the repair of articular cartilage defects in mammals
GB9502022D0 (en) 1995-02-02 1995-03-22 Abuljadayel Ilham M S A method for preparing lymphohaematopoietic progenitor cells
US6410268B1 (en) 1996-03-18 2002-06-25 Human Genome Sciences, Inc. Polynucleotides encoding chemokine alpha-3
DE19814405C2 (de) * 1998-03-31 2000-03-02 Schastak Astrid Porphyrine und ihre Verwendung als Photosensitizer
US6515001B2 (en) * 2001-03-05 2003-02-04 Chemokine Therapeutic Corporation IL-8 receptor ligands-drugs for inflammatory and autoimmune diseases
WO2003018760A2 (en) * 2001-08-24 2003-03-06 Advanced Cell Technology, Inc. Screening assays for identifying differentiation-inducing agents and production of differentiated cells for cell therapy
EP1312614A1 (de) 2001-11-16 2003-05-21 GenOdyssee Polynukleotide und Polypeptide des GCP-2 Gens
JP2003199816A (ja) * 2002-01-10 2003-07-15 Takehisa Matsuda 軟骨組織再生用補助材、軟骨組織再生用キット及び軟骨組織再生方法
JP4501688B2 (ja) * 2002-07-26 2010-07-14 味の素株式会社 新規ペプチド生成酵素遺伝子
CA2530533C (en) * 2003-06-27 2015-02-10 Ethicon, Incorporated Postpartum cells derived from umbilical cord tissue, and methods of making and using the same

Also Published As

Publication number Publication date
AU2004262451B2 (en) 2009-11-26
RU2363491C2 (ru) 2009-08-10
PL1653994T3 (pl) 2010-05-31
US7485310B2 (en) 2009-02-03
NZ545702A (en) 2008-08-29
JP4920412B2 (ja) 2012-04-18
NO20060464L (no) 2006-04-20
IL173544A0 (en) 2006-07-05
WO2005014026A2 (en) 2005-02-17
CA2533124A1 (en) 2005-02-17
RU2006107536A (ru) 2006-08-10
US20090117652A1 (en) 2009-05-07
ES2337469T3 (es) 2010-04-26
AU2004262451A1 (en) 2005-02-17
CA2533124C (en) 2014-01-28
EP1653994B1 (de) 2009-11-25
WO2005014026A3 (en) 2005-03-17
ATE449608T1 (de) 2009-12-15
DK1653994T3 (da) 2010-03-15
NO338152B1 (no) 2016-08-01
EP1653994A2 (de) 2006-05-10
HK1085656A1 (en) 2006-09-01
IL173544A (en) 2013-12-31
US7842502B2 (en) 2010-11-30
US20060246031A1 (en) 2006-11-02
JP2007501807A (ja) 2007-02-01

Similar Documents

Publication Publication Date Title
NO20060464L (no) Use of CXCL6 chemokine in the prevention or repair of cartilage defects
ATE435656T1 (de) Nkg2d modulation
BRPI0619579B8 (pt) Métodos para aumentar a expectativa de vida replicativa e/ou estabilidade de uma célula produtora de anticorpo, para expressar um gene de uma célula b codificando a cadeia pesada de ig e/ou cadeia leve de ig, para produzir linhagem de células b, para obter anticorpos, e, método ex vivo para produzir anticorpos capazes de especificamente ligar um antígeno de interesse
ATE342962T1 (de) Zusammensetzungen und verfahren für verbesserte zellkultur
EA200401591A1 (ru) Керамические аноды и способ их изготовления
DE602005023181D1 (de) Lentivirusvektoren und deren verwendung
CY1109267T1 (el) Μεθοδοι για την καλλιεργεια κυκλοϊου
ATE470702T1 (de) Verfahren zur herstellung von permanenten humanen zelllinien
TW200611910A (en) Interferon-alpha polypeptides and conjugates
DE602006018709D1 (de) Estergebundene geminitensidverbindungen zur verwendung in der gentherapie
ZA200701137B (en) Triazolophthalazines
DK1737950T3 (da) Celler, der udviser neuronal-progenitorcelle-karakteristika
MX2007010332A (es) Metodos y composiciones para promover adhesion o migracion de celula endotelial.
DE602004026445D1 (de) Verwendung von cardiotrophin zur modulation der stammzellenproliferation
DK1587526T3 (da) MNTF-peptider og sammensætninger og anvendelsesmåder
WO2005122723A3 (en) Compositions and methods that enhance articular cartilage repair
ATE369371T1 (de) 1-azadibenzoazulene als inhibitoren der produktion von tumornekrosefaktor und zwischenprodukte für deren herstellung
WO2003059932A3 (en) Methods of inducing or enhancing connective tissue repair
TW200643169A (en) The preparation of multipotent stem cells and the use thereof
ATE437846T1 (de) Cyclooct-(en-)yl-derivate zur verwendung als duftstoffe
DE60225530D1 (de) Phosphorylierte glyoxalase i und deren verwendung
GB0720502D0 (en) Markers of matrix gene expression and cellular differentiation in chondrocytes
ATE374243T1 (de) Knorpelzell-kulturmedium und verwendung desselben
BRPI0415446A (pt) recombinação mediada por flp
ATE464316T1 (de) Transiente immortalisierung von zellen durch onkogenproteine oder telomerproteine

Legal Events

Date Code Title Description
8364 No opposition during term of opposition